{
  "resourceType": "CodeSystem",
  "id": "substance-grade",
  "meta": {
    "lastUpdated": "2022-04-24T09:21:35.043+11:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
    ]
  },
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003eThis code system http://hl7.org/fhir/substance-grade defines the following codes:\u003c/p\u003e\u003ctable class\u003d\"codes\"\u003e\u003ctr\u003e\u003ctd style\u003d\"white-space:nowrap\"\u003e\u003cb\u003eCode\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDisplay\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd style\u003d\"white-space:nowrap\"\u003eUSP-NF\u003ca name\u003d\"substance-grade-USP-NF\"\u003e \u003c/a\u003e\u003c/td\u003e\u003ctd\u003eUSP/NF United States Pharmacopeia (USP) and the National Formulary (NF)\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd style\u003d\"white-space:nowrap\"\u003ePh.Eur\u003ca name\u003d\"substance-grade-Ph.46Eur\"\u003e \u003c/a\u003e\u003c/td\u003e\u003ctd\u003eEuropean Pharmacopoeia\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd style\u003d\"white-space:nowrap\"\u003eJP\u003ca name\u003d\"substance-grade-JP\"\u003e \u003c/a\u003e\u003c/td\u003e\u003ctd\u003eJapanese Pharmacopoeia\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd style\u003d\"white-space:nowrap\"\u003eBP\u003ca name\u003d\"substance-grade-BP\"\u003e \u003c/a\u003e\u003c/td\u003e\u003ctd\u003eBritish Pharmacopoeia\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd style\u003d\"white-space:nowrap\"\u003eCompanyStandard\u003ca name\u003d\"substance-grade-CompanyStandard\"\u003e \u003c/a\u003e\u003c/td\u003e\u003ctd\u003eCompany Standard\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/div\u003e"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "brr"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 1
    }
  ],
  "url": "http://hl7.org/fhir/substance-grade",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.1.1609"
    }
  ],
  "version": "4.3.0-cibuild",
  "name": "SubstanceGrade",
  "title": "SubstanceGrade",
  "status": "draft",
  "experimental": false,
  "date": "2021-01-05T10:01:24+11:00",
  "publisher": "HL7 (FHIR Project)",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org/fhir"
        },
        {
          "system": "email",
          "value": "fhir@lists.hl7.org"
        }
      ]
    }
  ],
  "caseSensitive": true,
  "valueSet": "http://hl7.org/fhir/ValueSet/substance-grade",
  "content": "complete",
  "concept": [
    {
      "code": "USP-NF",
      "display": "USP/NF United States Pharmacopeia (USP) and the National Formulary (NF)"
    },
    {
      "code": "Ph.Eur",
      "display": "European Pharmacopoeia"
    },
    {
      "code": "JP",
      "display": "Japanese Pharmacopoeia"
    },
    {
      "code": "BP",
      "display": "British Pharmacopoeia"
    },
    {
      "code": "CompanyStandard",
      "display": "Company Standard"
    }
  ]
}